Company / Return on Equity (ROE)
Evolent Health, Inc. Return on Equity (ROE) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-15.6%
FY2025
5-year range
-15.6% / -2.2%
FY2021-FY2025
Trend
-153.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Evolent Health, Inc. reports negative total equity of -15.6% in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-15.6% in FY2025 with a 5-year CAGR of +38.4%.
Declined from -10.6% to -15.6% over the past 2 years.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -13.3pp
- 5-Year Change
- +38.4pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on equity (roe) decreased 153.0% year-over-year.
- Peak return on equity (roe) was recorded in FY2022.
- Lowest return on equity (roe) in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.84 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -15.6% | -153.0% |
| FY2024 | -6.2% | +41.9% |
| FY2023 | -10.6% | -374.9% |
| FY2022 | -2.2% | +58.9% |
| FY2021 | -5.4% | +90.0% |
| FY2020 | -53.9% | -66.0% |
| FY2019 | -32.5% | -606.5% |
| FY2018 | -4.6% | +23.3% |
| FY2017 | -6.0% | +73.6% |
| FY2016 | -22.7% | -144.4% |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026